ストックスクリーナーアプリを入手
22.63
0.79%
-0.18
Tyra Biosciences Inc (TYRA) 最新ニュース
Understanding the Setup: (TYRA) and Scalable Risk - news.stocktradersdaily.com
How Investors Are Reacting To Tyra Biosciences (TYRA) Bolstering Its Regulatory And Oncology Leadership - Sahm
Tyra Biosciences stock hits 52-week high at 22.83 USD By Investing.com - Investing.com Canada
Tyra Biosciences stock hits 52-week high at 22.83 USD - Investing.com
June Brings on Some Huge Insider Buying - AOL.com
Tyra Biosciences (NASDAQ:TYRA) Raised to “Hold” at Wall Street Zen - Defense World
What makes Tyra Biosciences Inc. stock attractive to growth funds2025 Pullback Review & Stock Portfolio Risk Management - Newser
Aug Mood: Why Tyra Biosciences Inc. stock attracts high net worth investorsJuly 2025 Chart Watch & High Win Rate Trade Tips - moha.gov.vn
Can Tyra Biosciences Inc. stock resist market sell offsJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - Newser
Goldman Sachs initiates coverage of Tyra Biosciences stock with Early-Stage Biotech rating - Investing.com UK
Tyra Biosciences (TYRA): Assessing Valuation After New Leadership Hires to Drive Dabogratinib Pipeline Forward - Sahm
Sio Capital Management LLC Has $7.75 Million Position in Tyra Biosciences, Inc. $TYRA - MarketBeat
Tyra Biosciences (TYRA) Stock Analysis Report | Financials & Insights - Benzinga
Should Tyra Biosciences’ (TYRA) Executive Hires Shift the Regulatory Outlook for Its Pipeline? - Sahm
Tyra Biosciences (NASDAQ:TYRA) Shares Gap DownHere's What Happened - MarketBeat
Tyra Biosciences appoints two key executives to leadership team By Investing.com - Investing.com Canada
Novo Nordisk’s Miriam Frieden to lead BD at Lundbeck - BioCentury
Tyra Biosciences appoints two key executives to leadership team - Investing.com
Tyra Biosciences Announces Executive Role Changes - TradingView
Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer - Eastern Progress
Contrasting Milestone Pharmaceuticals (NASDAQ:MIST) and Tyra Biosciences (NASDAQ:TYRA) - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Bull Bear: How Tyra Biosciences Inc. stock reacts to global recession fearsMarket Weekly Review & Weekly Chart Analysis and Guides - moha.gov.vn
Weekly Recap: Why Tyra Biosciences Inc. stock attracts high net worth investorsLong Setup & Fast Exit and Entry Strategy Plans - moha.gov.vn
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year HighWhat's Next? - MarketBeat
Dynamic Technology Lab Private Ltd Takes $326,000 Position in Tyra Biosciences, Inc. $TYRA - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Director Robert More Sells 246,871 Shares - MarketBeat
Tyra Biosciences (TYRA): Evaluating Valuation Following Phase 2 Milestone in Achondroplasia Pipeline - simplywall.st
Dir More Sells 246,871 ($5M) Of Tyra Biosciences Inc [TYRA] - TradingView
Check Out Tyra Biosciences Inc (TYRA)’s Trade Data Rather Than the Analysts’ Views - Setenews
Immunic Inc (IMUX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Non Muscle Invasive Bladder Cancer Pipeline Insights Report 2025: Emerging Therapies and Key Clinical Advances Reshaping the Future of Treatment - Barchart.com
Best Growth Stocks To Follow Today – November 22nd - Defense World
Insiders Who Sold US$628k Of Tyra Biosciences Made The Right Call - simplywall.st
Why Tyra Biosciences (TYRA) Is Up 34.3% After Launching Phase 2 Trial in Pediatric Achondroplasia - Sahm
Tyra Biosciences stock hits 52-week high at 21.19 USD By Investing.com - Investing.com Nigeria
What Makes Shree Ganesh Bio a Strong Contender in YEARHigh Frequency Trading Trends & Free Exceptional Risk Adjusted Gains - earlytimes.in
Tyra Biosciences stock hits 52-week high at 21.19 USD - Investing.com
There is no doubt that Tyra Biosciences Inc (TYRA) ticks all the boxes. - Setenews
Tyra Biosciences Insider Sold Shares Worth $2,030,923, According to a Recent SEC Filing - MarketScreener
Tyra Biosciences COO Bensen sells $2m in stock By Investing.com - Investing.com India
Is Tyra Biosciences Inc. stock supported by strong fundamentalsJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Insider Sell: Daniel Bensen Sells 125,589 Shares of Tyra Bioscie - GuruFocus
Risk vs reward if holding onto Tyra Biosciences Inc.Weekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com
Can technical indicators confirm Tyra Biosciences Inc.’s reversalQuarterly Earnings Report & Expert Curated Trade Ideas - newser.com
Will Tyra Biosciences Inc. continue its uptrendEarnings Risk Report & Fast Gain Stock Tips - newser.com
Should I hold or sell Tyra Biosciences Inc. stock in 2025Trade Volume Summary & Daily Stock Trend Watchlist - newser.com
Is Tyra Biosciences Inc. forming a reversal patternMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
Has Tyra Biosciences Inc. found a price floorJobs Report & Momentum Based Trading Signals - newser.com
How to track smart money flows in Tyra Biosciences Inc.2025 Technical Patterns & Fast Entry Momentum Alerts - newser.com
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):